Paul Huggins has worked with Novo Nordisk since 1996 and holds his current position of corporate vice president – Biopharm Operations since 2010. The biopharm operations organisation resides in Zurich, Switzerland and comprises medical affairs and marketing functions with global responsibility for the therapeutic areas of haemophilia, growth disorders and women’s health. As an employee of Novo Nordisk in both the global and country-specific organisations, Paul Huggins has enjoyed working with the haemophilia and rare bleeding disorder community for the past 16 years.
Prior to joining Novo Nordisk, Paul Huggins worked for Ciba-Geigy (now Novartis) for 9 years, starting his career in the Canadian Sales organisation. Since then, Paul Huggins has lived and worked in Germany, Switzerland and Australia.
Paul Huggins holds an MBA degree from York University in Toronto, Canada and a BA Hons in Business and Germanic Studies from the University of Sheffield, United Kingdom.